Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, et al. and the WHO: Why? J Clin Oncol. 2024;42:984–6.
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36:1703–19.
Article PubMed PubMed Central Google Scholar
Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34:966–84.
Article CAS PubMed PubMed Central Google Scholar
Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KC, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 2022;140:1200–28.
Article CAS PubMed PubMed Central Google Scholar
Shah NP, Bhatia R, Altman JK, Amaya M, Begna KH, Berman E, et al. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22:43–69.
Article CAS PubMed Google Scholar
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.
Article CAS PubMed Google Scholar
Kantarjian HM, Tefferi A. Classification of accelerated phase chronic myeloid leukemia in the era of the BCR::ABL1 tyrosine kinase inhibitors: A work in progress. Am J Hematol. 2023;98:1350–3.
Article CAS PubMed Google Scholar
Shih LY, Chiu WF, Dunn P, Liaw SJ. In vitro culture studies of blood and marrow cells in chronic myeloid leukemia at different phases of the disease. Blut. 1988;57:125–30.
Article CAS PubMed Google Scholar
Anklesaria PN, Advani SH, Bhisey AN. Studies on granulocyte functions in patients with chronic myeloid leukemia. Tumori. 1985;71:317–23.
Article CAS PubMed Google Scholar
Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 1989;73:117–22.
Article CAS PubMed Google Scholar
Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B, et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA. 2006;103:2794–9.
Article CAS PubMed PubMed Central Google Scholar
Karanas A, Silver RT. Characteristics of the terminal phase of chronic granulocytic leukemia. Blood. 1968;33:445–59.
Yang S, Zhang X, Gale RP, Jiang Q. Goodbye to accelerated phase of chronic myeloid leukaemia. Submitted.
Lauseker M, Hehlmann R, Hochhaus A, Saußele S. Survival with chronic myeloid leukaemia after failing milestones. Leukemia. 2023;37:2231–6.
Article CAS PubMed PubMed Central Google Scholar
Hehlmann R, Lauseker M, Voskanyan A, Fabarius A, Haferlach C, Hochhaus A, et al. Impact of emerging ACA on survival in chronic myeloid leukemia (CML). Leukemia. 2022;36:2544–47.
Article PubMed PubMed Central Google Scholar
Sakurai M, Hayata I, Sandberg AA. Prognostic value of chromosomal findings in Ph1-positive chronic myelocytic leukemia. Cancer Res. 1976;36:313–8.
Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res. 2013;179:361–82.
Article CAS PubMed Google Scholar
Gale RP. Radiation and leukaemia: Which leukaemias and what doses? Blood Rev. 2023;58:1010–17. https://doi.org/10.1016/j.blre.2022.101017
Aurer I, Juhbashi T, Sekine I, Tomonaga M, Gale RP. Analysis of BCR/ABL abnormalities in mRNA from 20-year-old paraffin-embedded tissue for BCR/ABL rearrangement by polymerase chain reaction. Acta Haematol. 1993;90:5–7.
Article CAS PubMed Google Scholar
Morrow GW Jr, Pease CL, Stroebel CF, Bennett WA. Terminal phase of chronic myelogenous leukemia. Cancer 1965;18:369.
留言 (0)